First Hawaiian Bank Abiomed Inc Transaction History

First Hawaiian Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 08, 2021	SELL	$262.71 - $351.17 $488,903 - $653,527	-1,861 Closed	0 $0
Q1 2021 Apr 09, 2021	SELL	$285.92 - $355.13 $27,162 - $33,737	-95 Reduced 4.86%	1,861 $593,000
Q4 2020 Jan 12, 2021	SELL	$251.88 - $324.2 $23,928 - $30,799	-95 Reduced 4.63%	1,956 $634,000
Q3 2020 Oct 06, 2020	BUY	$255.22 - $317.0 $523,456 - $650,167	2,051 New	2,051 $568,000
Q3 2019 Oct 03, 2019	SELL	$175.89 - $279.23 $315,018 - $500,100	-1,791 Closed	0 $0
Q2 2019 Jul 15, 2019	SELL	$250.96 - $284.94 $260,998 - $296,337	-1,040 Reduced 36.74%	1,791 $467,000
Q1 2019 Apr 02, 2019	BUY	$276.39 - $362.25 $256,489 - $336,168	928 Added 48.77%	2,831 $809,000
Q4 2018 Jan 11, 2019	SELL	$281.08 - $444.25 $56,216 - $88,850	-200 Reduced 9.51%	1,903 $619,000
Q3 2018 Oct 16, 2018	BUY	$354.53 - $449.75 $745,576 - $945,824	2,103 New	2,103 $946,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.